https://orcid.org/0000-0002-7365-7455
References
- Al-Massarani SM, El Gamal AA, Al-Musayeib NM, Mothana RA, Basudan OA, Al-Rehaily AJ, Farag M, Assaf MH, El Tahir KH, Maes L. 2013. Phytochemical, antimicrobial and antiprotozoal evaluation of Garcinia mangostana pericarp and α-mangostin, its major xanthone derivative. Molecules. 18(9):10599–10608.
- Butler MS. 2004. The role of natural product chemistry in drug discovery. J Nat Prod. 67(12):2141–2153.
- Cragg GM, Newman DJ, Snader KM. 1997. For an outstanding analysis of the role of natural products in pharmaceuticals. J Nat Prod. 60(1):52–60.
- CRC Press. 2021. Dictionary of natural products 30.2 Taylor & Francis Group [accessed 2022 Mar 10] https://dnp.chemnetbase.com/faces/chemical/ChemicalSearch.xhtml.
- Edmonds DJ, Price DA. 2013. Oral GLP-1 modulators for the treatment of diabetes. Annu Rep Med Chem. 48:119–130.
- Ee GCL,Daud S,Taufiq-Yap YH,Ismail NH,Rahmani M. 2006. Xanthones from Garcinia mangostana (Guttiferae). Nat Prod Res. 20(12):1067–1073. doi:10.1080/14786410500463114. 17127660
- Hansen K, Knop F, Holst JJ, Vilsbøll T. 2009. Treatment of type 2 diabetes with glucagon‐like peptide‐1 receptor agonists. Int J Clin Pract. 63(8):1154–1160.
- Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH. 2012. Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep. 29(5):580–606.
- Jung M,Park M,Lee HC,Kang Y-H,Kang ES,Kim SK. 2006. Antidiabetic agents from medicinal plants. Curr Med Chem. 13(10):1203–1218. doi:10.2174/092986706776360860. 16719780
- Khan RA. 2018. Natural products chemistry: the emerging trends and prospective goals. Saudi Pharm J. 26(5):739–753.
- Lee D, Kim YM, Jung K, Chin YW, Kang KS. 2018. Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. IJMS. 19(5):1484.
- Meier JJ. 2012. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 8(12):728–742.
- Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. 2004. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology. 145(2):667–678.
- Myrianthopoulos V, Lambrinidis G, Mikros E. 2018. In silico screening of compound libraries using a consensus of orthogonal methodologies. In: Rational drug design. Methods in molecular biology. New York, NY: Humana Press; p. 261–277.
- Newman DJ, Cragg GM. 2020. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 83(3):770–803.
- Olğaç A, Orhan IE, Banoglu E. 2017. The potential role of in silico approaches to identify novel bioactive molecules from natural resources. Future Med Chem. 9(14):1665–1686.
- Santiago CG, Paci E, Donnelly D. 2018. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics. Biochem Biophys Res Commun. 498(2):359–365.
- Sha Y, Shi Y, Niu B, Chen Q. 2017. Cochinchinenin C, a potential nonpolypeptide anti-diabetic drug, targets a glucagon-like peptide-1 receptor. RSC Adv. 7(77):49015–49023.
- Sharma S, Wadhwa K, Choudhary M, Budhwar V. 2021. Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus. Nat. Prod. Res. 35(1):1–15.
- Wootten D, Reynolds CA, Smith KJ, Mobarec JC, Koole C, Savage EE, Pabreja K, Simms J, Sridhar R, Furness SGB, et al. 2016. The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism. Cell. 165(7):1632–1643.